Archasappawat S, Al-Musawi F, Liu P, Lee E, Hwang C
Biomolecules. 2024; 14(11).
PMID: 39595558
PMC: 11592027.
DOI: 10.3390/biom14111381.
Colombo C, Casari E, Gnugnoli M, Corallo F, Tisi R, Longhese M
Nucleic Acids Res. 2024; 52(22):13849-13864.
PMID: 39558159
PMC: 11662671.
DOI: 10.1093/nar/gkae1049.
Zhao Y, Hou K, Liu Y, Na Y, Li C, Luo H
Int J Mol Sci. 2024; 25(16).
PMID: 39201320
PMC: 11355030.
DOI: 10.3390/ijms25168634.
van de Kooij B, van der Wal F, Rother M, Wiegant W, Creixell P, Stout M
Nat Commun. 2024; 15(1):7076.
PMID: 39152113
PMC: 11329772.
DOI: 10.1038/s41467-024-51090-6.
Zhang C, Liu J, Wu J, Ranjan K, Cui X, Wang X
Front Cell Dev Biol. 2024; 12:1422520.
PMID: 39050891
PMC: 11266142.
DOI: 10.3389/fcell.2024.1422520.
DNA binding and bridging by human CtIP in the healthy and diseased states.
Lokanathan Balaji S, De Braganca S, Balaguer-Perez F, Northall S, Wilkinson O, Aicart-Ramos C
Nucleic Acids Res. 2024; 52(14):8303-8319.
PMID: 38922686
PMC: 11317151.
DOI: 10.1093/nar/gkae538.
Small-Molecule Inhibition of CBX4/7 Hypersensitises Homologous Recombination-Impaired Cancer to Radiation by Compromising CtIP-Mediated DNA End Resection.
Osborne H, Foster B, Al-Hazmi H, Meyer S, Larrosa I, Schmidt C
Cancers (Basel). 2024; 16(11).
PMID: 38893273
PMC: 11172190.
DOI: 10.3390/cancers16112155.
Binding of the TRF2 iDDR motif to RAD50 highlights a convergent evolutionary strategy to inactivate MRN at telomeres.
Khayat F, Alshmery M, Pal M, Oliver A, Bianchi A
Nucleic Acids Res. 2024; 52(13):7704-7719.
PMID: 38884214
PMC: 11260466.
DOI: 10.1093/nar/gkae509.
Structure-specific nucleases in genome dynamics and strategies for targeting cancers.
Sun H, Luo M, Zhou M, Zheng L, Li H, Esworthy R
J Mol Cell Biol. 2024; 16(5).
PMID: 38714348
PMC: 11574390.
DOI: 10.1093/jmcb/mjae019.
The impact of developmental stage, tissue type, and sex on DNA double-strand break repair in Drosophila melanogaster.
Graham E, Fernandez J, Gandhi S, Choudhry I, Kellam N, LaRocque J
PLoS Genet. 2024; 20(4):e1011250.
PMID: 38683763
PMC: 11057719.
DOI: 10.1371/journal.pgen.1011250.
Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.
Zhou Q, Tu X, Hou X, Yu J, Zhao F, Huang J
Drug Resist Updat. 2024; 74:101085.
PMID: 38636338
PMC: 11095636.
DOI: 10.1016/j.drup.2024.101085.
Dbf4-dependent kinase promotes cell cycle controlled resection of DNA double-strand breaks and repair by homologous recombination.
Galanti L, Peritore M, Gnugge R, Cannavo E, Heipke J, Palumbieri M
Nat Commun. 2024; 15(1):2890.
PMID: 38570537
PMC: 10991553.
DOI: 10.1038/s41467-024-46951-z.
Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets.
Sofianidi A, Dumbrava E, Syrigos K, Nasrazadani A
Cancers (Basel). 2024; 16(6).
PMID: 38539474
PMC: 10969473.
DOI: 10.3390/cancers16061139.
CDK-independent role of D-type cyclins in regulating DNA mismatch repair.
Rona G, Miwatani-Minter B, Zhang Q, Goldberg H, Kerzhnerman M, Howard J
Mol Cell. 2024; 84(7):1224-1242.e13.
PMID: 38458201
PMC: 10997477.
DOI: 10.1016/j.molcel.2024.02.010.
CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice.
Alfano L, Iannuzzi C, Barone D, Forte I, Ragosta M, Cuomo M
Oncogene. 2024; 43(17):1263-1273.
PMID: 38433256
DOI: 10.1038/s41388-024-02982-w.
NUDT16 regulates CtIP PARylation to dictate homologous recombination repair.
Zhang Z, Samsa W, Gong Z
Nucleic Acids Res. 2024; 52(7):3761-3777.
PMID: 38324469
PMC: 11039996.
DOI: 10.1093/nar/gkae064.
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Yu Z, Deng P, Chen Y, Lin D, Liu S, Hong J
Proc Natl Acad Sci U S A. 2024; 121(6):e2304619121.
PMID: 38289962
PMC: 10861914.
DOI: 10.1073/pnas.2304619121.
D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stability.
Rona G, Miwatani-Minter B, Zhang Q, Goldberg H, Kerzhnerman M, Howard J
bioRxiv. 2024; .
PMID: 38260436
PMC: 10802603.
DOI: 10.1101/2024.01.12.575420.
Suppression of NBS1 Upregulates CyclinB to Induce Olaparib Sensitivity in Ovarian Cancer.
Zhong A, Cheng C, Lu R, Guo L
Technol Cancer Res Treat. 2024; 23:15330338231212085.
PMID: 38192153
PMC: 10777771.
DOI: 10.1177/15330338231212085.
ATM/ATR Phosphorylation of CtIP on Its Conserved Sae2-like Domain Is Required for Genotoxin-Induced DNA Resection but Dispensable for Animal Development.
Wu-Baer F, Wong M, Tschoe L, Lin C, Jiang W, Zha S
Cells. 2023; 12(23).
PMID: 38067190
PMC: 10706839.
DOI: 10.3390/cells12232762.